Asparaginase erwinia chrysanthemi Intramuscular and Copanlisib

• Generic Name: asparaginase erwinia chrysanthemi
• Dosage Forms: n.a.
• Other Brand Names: Erwinaze

Asparaginase Erwinia chrysanthemi is used together with other cancer medicines to treat a certain type of blood cancer called acute lymphoblastic leukemia (ALL). Asparaginase erwinia chrysanthemi is used in patients who have had an allergic reaction to E. coli-derived asparaginase.

Asparaginase Erwinia chrysanthemi belongs to the group of medicines known as antineoplastic agents. It interferes with the growth of the cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by asparaginase erwinia chrysanthemi, other effects will also occur. Some of these may be serious and must be reported to your doctor.

Before you begin treatment with Erwinaze®, you and your doctor should talk about the benefits of asparaginase erwinia chrysanthemi as well as the risks of using it.

Asparaginase erwinia chrysanthemi is to be given only by or under the immediate supervision of your doctor.

• Generic Name: copanlisib
• Dosage Forms: n.a.
• Other Brand Names: Aliqopa

Copanlisib is used to treat follicular lymphoma that has relapsed after treatment with at least two other medicines.

Copanlisib was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to copanlisib, but further studies are needed.

Copanlisib may also be used for purposes not listed in this medication guide.